Machida, T., Gong, Y., Tsukioka, S., Onodera, A., Nakayama, A., Hashimoto, N., Fuchigami, T., Nishimura, M., Ogino, T., Kurimoto, R., Uematsu, Y., Suzuki, H., Yu, H., Chen, M., Yokoyama, M., Sakuma, I., Taki, Y., Kono, T., Miki, T., Motohashi, S., Kawashima, Y., Ohara, O., Yamashita, S., Suzuki, T., Hatanaka, R., Kodama, Y., Ohkubo, S., Tanaka, T. (2026). LSD1 inhibitor, TAS1440, disrupts INSM1-LSD1 complex activating tumor-suppressive pathways via transcriptional reprogramming in neuroendocrine SCLC. Nature Communications. https://doi.org/10.1038/s41467-026-70984-1